Federal contract award
75A50124C00037
CAPTURE BIOSCIENCE, INC. R&D FOR BEADS BY TIME-OF-FLIGHT. ISOTOPE-BASED TECHNOLOGY ENABLING HIGHLY SCALABLE MULTIPLEX SEROLOGY. AREA OF INTEREST NO: #23 (HOST-BASED DIAGNOSTICS)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $750.0K |
| Current contract value | $750.0K |
| Potential contract value / ceiling | $750.0K |
| Start date | Sep 1, 2024 |
| Current end date | Nov 30, 2026 |
| Potential end date | Nov 30, 2026 |
| Latest award activity | Aug 4, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 4, 2026 | P00005 | $0 | CAPTURE BIOSCIENCE, INC. R&D FOR BEADS BY TIME-OF-FLIGHT. ISOTOPE-BASED TECHNOLOGY ENABLING HIGHLY SCALABLE MULTIPLEX SEROLOGY. AREA OF INTEREST NO: #23 (HOST-BASED DIAGNOSTICS) |
| Nov 18, 2025 | P00004 | $0 | CAPTURE BIOSCIENCE, INC. R&D FOR BEADS BY TIME-OF-FLIGHT. ISOTOPE-BASED TECHNOLOGY ENABLING HIGHLY SCALABLE MULTIPLEX SEROLOGY. AREA OF INTEREST NO: #23 (HOST-BASED DIAGNOSTICS) |
| May 19, 2025 | P00003 | $0 | CAPTURE BIOSCIENCE, INC. R&D FOR BEADS BY TIME-OF-FLIGHT. ISOTOPE-BASED TECHNOLOGY ENABLING HIGHLY SCALABLE MULTIPLEX SEROLOGY. AREA OF INTEREST NO: #23 (HOST-BASED DIAGNOSTICS) |
| May 2, 2025 | P00002 | $0 | CAPTURE BIOSCIENCE, INC. R&D FOR BEADS BY TIME-OF-FLIGHT. ISOTOPE-BASED TECHNOLOGY ENABLING HIGHLY SCALABLE MULTIPLEX SEROLOGY. AREA OF INTEREST NO: #23 (HOST-BASED DIAGNOSTICS) |
| Apr 3, 2025 | P00001 | $0 | CAPTURE BIOSCIENCE, INC. R&D FOR BEADS BY TIME-OF-FLIGHT. ISOTOPE-BASED TECHNOLOGY ENABLING HIGHLY SCALABLE MULTIPLEX SEROLOGY. AREA OF INTEREST NO: #23 (HOST-BASED DIAGNOSTICS) |
| Aug 27, 2024 | 0 | $750.0K | CAPTURE BIOSCIENCE, INC. R&D FOR BEADS BY TIME-OF-FLIGHT. ISOTOPE-BASED TECHNOLOGY ENABLING HIGHLY SCALABLE MULTIPLEX SEROLOGY. AREA OF INTEREST NO: #23 (HOST-BASED DIAGNOSTICS) |
Estimated positioning window
Nov 1, 2026 – Jan 30, 2027
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2026-11-30 (29 days from calculation)
- +35 points
- 121 historical awards in this buyer and category group
- +15 points
- 6 recorded award transactions
- +10 points
- Latest award action: 2026-08-04
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.